rosiglitazone has been researched along with Cystic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, Z; Ong, AC; Streets, AJ | 1 |
1 other study(ies) available for rosiglitazone and Cystic Kidney Diseases
| Article | Year |
|---|---|
Thiazolidinediones inhibit MDCK cyst growth through disrupting oriented cell division and apicobasal polarity.
Topics: Animals; Apoptosis; Cadherins; Cell Division; Cell Line; Cell Polarity; Cell Proliferation; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Kidney; Kidney Diseases, Cystic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Time Factors | 2011 |